ArticleFrontiers in immunology2023

Targeting STAT3 in tumor-associated antigen-presenting cells as a strategy for kidney and bladder cancer immunotherapy.

Marice B Alcantara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.